ash 2022 astx low dose - SERP Analysis

https://astx.com/2022-ash-astx727-03-phase-1-study-evaluating-oral-decitabine-cedazuridine-astx727-low-dose-ld-in-lower-risk-myelodysplastic-syndromes-lr-mds-patients/

https://astx.com/wp-content/uploads/2022/12/2022_ASTX727_Oral_ASH_abst-461_Garcia-Manero2-1.pdf

https://www.taihooncology.com/us/news/2022-12-12_toi_astex_ash_2022_data/

https://ascopost.com/issues/february-10-2023/quick-takes-on-important-cancer-research-from-ash-2022/

https://ashpublications.org/blood/article/140/Supplement%201/1595/487913/Outcomes-of-Subsequent-Anti-Lymphoma-Therapies-in

https://clinicaloptions.com/program/oncology/2022-ash-annual-meeting/100002182

https://www.ohsu.edu/sites/default/files/2023-01/06%29%20Myeloma%20Update%20%281%29.pdf

https://onco-hema.healthbooktimes.org/article/73786-hematologic-updates-from-ash-2022

https://news.bms.com/news/details/2022/Bristol-Myers-Squibb-Data-at-ASH-2022-Highlight-Innovative-Therapeutic-Platforms-Across-a-Range-of-Blood-Diseases/default.aspx

https://www.vumedi.com/channel/ash-2022-conference-coverage/tab/myeloma-29/

https://ashpublications.org/blood/article/142/Supplement%201/6728/501312/A-Phase-II-Study-of-Isatuximab-in-Combination-with

https://conferences.medicom-publishers.com/wp-content/uploads/2023/02/E-ASH-MCR-2022.pdf

https://www.targetedonc.com/view/kumar-reviews-key-trials-on-multiple-myeloma-presented-at-ash-2022

https://themmrf.org/uncategorized/mmrf-ash-2022-blog-ash-day-1/

https://ascentage.com/live-from-ash-2022-ascentage-pharma-presents-latest-data-of-apg-2575-including-encouraging-results-of-the-combination-with-btki-in-patients-with-r-r-cll-sll/

https://www.sciencedirect.com/journal/blood/vol/140/suppl/S2

https://assets.roche.com/f/176343/x/937c65da06/ash-investor-event-2022.pdf

https://news.bms.com/news/details/2022/Bristol-Myers-Squibb-Announces-First-Disclosures-and-New-Data-at-ASH-2022-Demonstrating-Commitment-to-Raising-Standards-in-Treatment-Through-Broad-Multiple-Myeloma-Portfolio/default.aspx

https://sohoonline.org/SOHO/SOHO/News/Final-Sintra-Rev-Results-Favor-Lenalidomide-Non-Transfusion-Dependent-Low-Risk-MDS.aspx

https://www.takedaoncology.com/news/news-releases/american-society-of-hematology-ash/

https://www.jnj.com/media-center/press-releases/janssen-to-highlight-latest-scientific-advances-in-hematologic-diseases-at-ash-2022-with-clinical-and-real-world-data-across-innovative-pipeline-and-distinguished-portfolio

https://ir.sellaslifesciences.com/news/News-Details/2022/SELLAS-Announces-Positive-Phase-1-Data-with-CDK9-Inhibitor-GFH009-Monotherapy-in-Patients-with-RelapsedRefractory-Hematologic-Malignancies/default.aspx

https://manage.ercongressi.it/storage/ercongressi/act/pdf/196/12646-2.%20BRINGHEN.pdf

https://onco-hema.healthbooktimes.org/api/v1/articles/73786-hematologic-updates-from-ash-2022.pdf

https://www.hoparx.org/resources/summaries-of-allied-organization-meetings/2022-american-society-of-hematology-ash-annual-meeting/

https://www.gene.com/media/press-releases/14977/2022-12-12/genentech-presents-new-data-demonstratin

https://ash.confex.com/ash/2023/webprogram/authora.html

https://www.hematology.org/-/media/hematology/files/annual-meeting/schedule-and-program/2022-program-book.pdf?la=en&hash=644617586269BF9A95772C71F83FB294

https://link.springer.com/article/10.1007/s12254-023-00898-x

https://www.hematologyadvisor.com/reports/myelodysplastic-syndrome-updates-ash-2022-annual-meeting-treatment-risk/2/

https://www.bioworld.com/articles/692414-conference-data-for-dec-14-2022-ash

https://www.vjhemonc.com/feature/ash-press-late-breaking-abstract-rundown/

https://www.biospace.com/astex-announces-that-the-phase-3-ascertain-acute-myeloid-leukemia-aml-clinical-study-of-oral-hypomethylating-agent-decitabine-and-cedazuridine-fixed-dose-combination-astx727-or-dec-c-met-the-trial-s-primary-endpoint

https://www.unmc.edu/cce/_archived/2023/live/hematology-highlights/attendee-info/02_zeidan.pdf

https://investors.artivabio.com/News-and-Events/news/news-details/2022/Artiva-Announces-Abstract-Accepted-for-Presentation-at-the-64th-American-Society-of-Hematology-Annual-Meeting--Exposition/default.aspx

https://asset.researchtopractice.com/2023/Webinar/YIR2022_MM_Jan10.pdf

https://ir.geron.com/investors/press-releases/press-release-details/2022/Geron-Announces-Presentations-at-Upcoming-ASH-Annual-Meeting-Including-Long-term-Phase-2-Data-Showing-Continuous-Durable-Transfusion-Independence-in-Patients-with-Lower-Risk-MDS/default.aspx

https://www.cdc.gov/mmwr/volumes/71/rr/rr7103a1.htm

https://journals.lww.com/hemasphere/fulltext/2022/06003/abstract_book_for_the_27th_congress_of_the.1.aspx

https://www.jacc.org/doi/10.1016/j.jacadv.2025.101883

https://www.mds-foundation.org/api/file/file/dr_kagan_s_slides_-_condensed_pdf-1720444004.pdf

https://pmc.ncbi.nlm.nih.gov/articles/PMC7903232/

https://www.hhs.texas.gov/sites/default/files/documents/apr-2023-durb-agenda-item3hh.pdf

https://www1.wfh.org/publications/files/pdf-1863.pdf

https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.983734/full

https://www.ahajournals.org/doi/10.1161/CIR.0000000000001063

https://academic.oup.com/eep/article/8/1/dvac025/6794046

https://www.aptitudehealth.com/wp-content/uploads/2023/01/20221214-Reports-EPICS-ASH-CC-Leukemia-Look-Inside.pdf

https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(22)00217-1/fulltext

https://www.news-medical.net/news/20230821/The-effect-of-low-dose-rate-exposure-to-ionising-radiation-on-the-risk-of-cancer.aspx

https://asset.researchtopractice.com/2022/Webinar/BCMA22_MM_2_Nov30.pdf

https://www.sciencedirect.com/science/article/pii/S2772963X25003035

https://journals.lww.com/crst/fulltext/2022/05030/venetoclax__a_narrative_drug_review.20.aspx

https://myeloma.org.au/wp-content/uploads/2022/06/MSAG-waldenstrom-guidelines-jun22.pdf

https://pmc.ncbi.nlm.nih.gov/articles/PMC9435593/

https://www.prnewswire.com/news-releases/taiho-oncology-and-astex-pharmaceuticals-present-overall-survival-data-for-oral-decitabine-and-cedazuridine-inqovi-astx727-in-patients-with-mds-and-cmml-harboring-tp53-mutations-at-64th-ash-annual-meeting-301700665.html

https://veri.larvol.com/news/actimab-a-lintuzumab-ac225/drug

https://ir.shattucklabs.com/investors/news-events/press-releases/news-details/2023/Shattuck-Labs-to-Present-Topline-Data-from-Phase-1-AB-Clinical-Trial-of-SL-172154-in-RelapsedRefractory-RR-Acute-Myeloid-Leukemia-AML-and-Higher-Risk-Myelodysplastic-Syndromes-HR-MDS-Patients-at-the-American-Society-of-Hematology-ASH-2023-Annual-Meet/default.aspx

https://s29.q4cdn.com/837489692/files/doc_presentations/2023/Dec/11/arcellx-ir-event-at-65th-ash-meeting-12-11-2023.pdf

https://sohoonline.org/SOHO/SOHO/News/Phase%20I%20Dose%20Expansion%20Readout%20for%20Epcoritamab%20in%20High-Risk%20Follicular%20Lymphoma.aspx

https://www.thebloodproject.com/wp-content/uploads/2022/07/ASH.pdf

https://www.news-medical.net/news/20221212/Novel-drug-shows-early-potential-in-combating-multiple-myeloma.aspx

https://ir.adctherapeutics.com/press-releases/press-release-details/2024/ADC-Therapeutics-Provides-Business-Updates/default.aspx

https://www.news.sanofi.us/2024-12-03-ASH-New-data-underscore-Sanofis-commitment-to-innovation-in-rare-blood-diseases-and-cancers

https://ir.geron.com/investors/press-releases/press-release-details/2022/Geron-Reports-Oral-Presentation-at-ASH-Annual-Meeting-Highlighting-Continuous-Long-Term-Transfusion-Independence-with-Imetelstat-Treatment-in-Lower-Risk-MDS-Patients/default.aspx

https://lymphoblastic-hub.com/medical-information/ash-2022-abstracts-what-s-hot-in-acute-lymphoblastic-leukemia/

https://www.jacc.org/doi/10.1016/j.jacc.2021.12.012

https://www.businesswire.com/news/home/20220512006061/en/Astex-Announces-That-the-Phase-3-ASCERTAIN---Acute-Myeloid-Leukemia-AML-Clinical-Study-of-Oral-Hypomethylating-Agent-Decitabine-and-Cedazuridine-Fixed-Dose-Combination-ASTX727-or-DEC-C-Met-the-Trials-Primary-Endpoint

https://www.targetedonc.com/view/actimab-a-triplet-trial-launches-in-frontline-aml

https://www.illinois.gov/

https://www.hematology.org/education/patients/anemia/iron-deficiency

https://ascopost.com/issues/february-25-2023-supplement-conference-highlights-ash-2022/highlights-from-the-2022-ash-annual-meeting-and-exposition/

https://www.healthline.com/nutrition/baking-soda-benefits-uses

https://www.news.sanofi.us/2022-12-02-Sanofi-to-showcase-new-data-from-oncology-portfolio-spanning-marketed-products-and-investigational-compounds-at-ASH-2022

https://ash.confex.com/ash/2023/webprogram/authord.html

https://ecancer.org/en/news/22480-ash-2022-new-data-for-talquetamab-a-first-in-class-gprc5dxcd3-bispecific-antibody-suggesting-durable-responses-in-patients-with-heavily-pretreated-multiple-myeloma

https://api-qa.hyundai.com.mx/default.aspx/Resources/Y69771/QuickbooksOnlineCertificat.pdf

https://investor.regeneron.com/static-files/3f2c8835-1da3-43e6-a50d-7080d8d935ab

https://www.unmc.edu/cce/_archived/2023/live/hematology-highlights/attendee-info/03_oehler.pdf